INBX fundamentals
An in-depth look to Inhibrx Biosciences, Inc. operating, investing, and financing activities
INBX free cash flow for Q2 24 is -58.57 M USD. For 2023, INBX free cash flow was -197.9 M USD and operating cash flow was -193.31 M USD.
Q1 '23
Q2 '23
Q1 '24
Q2 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q1 '23
Q2 '23
Q1 '24
Q2 '24
TTM